tiprankstipranks
RenovoRx (RNXT)
NASDAQ:RNXT
US Market
RNXT
RenovoRx
RESEARCH TOOLSreports

RenovoRx (RNXT) Income Statement

159 Followers

RenovoRx Income Statement

Last quarter (Q4 2025), RenovoRx's total revenue was $238.00K, an increase of 20.81% from the same quarter last year. In Q4, RenovoRx's net income was $-2.94M. See RenovoRx’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Dec 22Dec 21
Total Revenue
$ 1.12M$ 43.00K$ 0.00$ 0.00$ 0.00
Gross Profit
$ 796.00K$ 43.00K$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 13.31M$ 11.01M$ 11.40M$ 9.95M$ 5.67M
Depreciation and Amortization
$ 0.00$ 0.00$ 6.00K$ 6.00K$ 9.00K
EBITDA
$ -12.51M$ -10.97M$ -11.39M$ -9.94M$ -5.48M
Operating Income
$ -12.51M$ -10.97M$ -11.40M$ -9.95M$ -5.67M
Other Income/Expenses
$ 1.34M$ 2.16M$ 1.16M$ 61.00K$ -653.00K
Pretax Income
$ -11.17M$ -8.81M$ -10.23M$ -9.89M$ -6.32M
Net Income
$ -11.17M$ -8.81M$ -10.23M$ -9.89M$ -6.32M
Per Share Metrics
Basic EPS
$ -0.32$ -0.37$ -0.50$ -0.54$ -0.40
Diluted EPS
$ -0.32$ -0.37$ -0.50$ -0.54$ -0.40
Weighted Average Shares Outstanding
 35.33M 23.61M 20.58M 18.10M 17.87M
Weighted Average Shares Outstanding (Diluted)
 35.33M 23.61M 20.58M 18.10M 17.87M
Currency in USD

RenovoRx Earnings and Revenue History